v5 eVLP gag-pro-pol Citations (2)

Originally described in: Directed evolution of engineered virus-like particles with improved production and transduction efficiencies.
Raguram A, An M, Chen PZ, Liu DR Nat Biotechnol. 2024 Nov 13. doi: 10.1038/s41587-024-02467-x. PubMed Journal

---

Articles Citing v5 eVLP gag-pro-pol

Articles
FAME-CRISPR improves CRISPR-Cas9 genome editing via HDAC inhibition and engineered virus-like particle delivery. Djamshidi M, Hill A, Heshmatzad K, Langley J, Krowicki H, Ali M, Yang Y, Tanida R, Abdul-Careem MF, Billon P, Riabowol K. Cell Rep Methods. 2026 Jan 26;6(1):101248. doi: 10.1016/j.crmeth.2025.101248. Epub 2025 Dec 3. PubMed
Protocol for enhancing CRISPR-Cas9 genome editing using histone deacetylase inhibition and engineered virus-like particle delivery. Djamshidi M, Tanida R, Heshmatzad K, Krowicki H, Hill A, Yang Y, Riabowol K. STAR Protoc. 2026 Jun 19;7(2):104493. doi: 10.1016/j.xpro.2026.104493. Epub 2026 Apr 20. PubMed

If you have published an article using this material, please email us at to have your article added to this page.